According to an article in Medical News Today, a single dose of psilocybin - the psychedelic compound in magic mushrooms - may reduce anxiety and depression in patients with advanced cancer, according to the results of two new studies.
Both studies - conducted by investigators from the NYU Langone Medical Center in New York, NY, and Johns Hopkins Medicine in Baltimore, MD - were recently published in the Journal of Psychopharmacology.
Psilocybin is a substance present in various mushrooms - often called magic mushrooms or "shrooms" - found in Europe, South America, and the United States.
Psilocybin is a Schedule I substance under America's Controlled Substances Act, which means it is deemed as having "a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision."
The new study, however, suggests there may be a medical...
Dear Friend of NCADD ... It takes courage, determination and strength to avoid alcohol and drugs or to seek help and overcome addiction. We want to do everything in our power to provide the tools and support to help those on this journey. Without question, this is the most important journey of their lives and your support makes a huge difference in its outcome! On behalf of all those on the journey to recovery, and of all those waiting to start that journey, we thank you. Donate Now